SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000905718-20-000516
Filing Date
2020-05-28
Accepted
2020-05-28 17:00:05
Documents
1
Group Members
TIMBER PHARMACEUTICALS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A timber_13dam1may182020.htm SC 13D/A 53479
  Complete submission text file 0000905718-20-000516.txt   55189
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: SC 13D/A | Act: 34 | File No.: 005-87755 | Film No.: 20922076
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677 201-645-4767
TardiMed Sciences LLC (Filed by) CIK: 0001800690 (see all company filings)

IRS No.: 452297650 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13D/A